Indolizinylethylamine

Indolizinylethylamines are a group of indolizine derivatives closely related to the tryptamines (indolylethylamines). They include 2ZEDMA, 1ZP2MA, and 1Z2MAP1O. Indolizinylethylamines are known to act as non-hallucinogenic serotonin receptor agonists and as monoamine releasing agents.[1][2]

Chemical structures of selected indolizinylethylamines

See also

References

  1. ^ WO patent 2023183613A2, Matthew J. Baggott, "Indolizine compounds for the treatment of mental disorders or inflammation", published 2023 September 28, assigned to Tactogen 
  2. ^ WO application 2023081306A1, Baggott MJ, "Indolizine compounds for the treatment of mental disorders or mental enhancement", published 11 May 2023, assigned to Tactogen 



This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.